![Marc Struhalla](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marc Struhalla
Amministratore Delegato presso c-LEcta GmbH
Profilo
Marc Struhalla is the founder and currently serves as the Chief Executive Officer & Co-Managing Director of c-LEcta GmbH, a company he founded in 2004.
He holds a doctorate degree from the University of Hamburg and an undergraduate degree from Universität Leipzig.
Posizioni attive di Marc Struhalla
Società | Posizione | Inizio |
---|---|---|
c-LEcta GmbH
![]() c-LEcta GmbH BiotechnologyHealth Technology c-LEcta GmbH operates as a industrial biotechnology company that discovers, optimizes, produces, and sells enzymes for research, development, bio-catalysis, diagnostics, and industrial applications. The firm focuses on the utilization of proteins with catalytic properties. It offers recombinant RNases, exonucleases, alcohol-dehydrogenases, lipases, and proteases for applications in research and development; biocatalysts for the production of chemicals; and starch, cellulose, and hemicellulose hydrolyzing enzymes, as well as lipases and proteases to use as components in detergents and cleaning products for the food and feed industry. The company was founded by Marc Struhalla and Thomas Greiner-St?ffele in 2004 and is headquartered in Leipzig, Germany. | Amministratore Delegato | 01/01/2004 |
Formazione di Marc Struhalla
Universität Leipzig | Undergraduate Degree |
University of Hamburg | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
c-LEcta GmbH
![]() c-LEcta GmbH BiotechnologyHealth Technology c-LEcta GmbH operates as a industrial biotechnology company that discovers, optimizes, produces, and sells enzymes for research, development, bio-catalysis, diagnostics, and industrial applications. The firm focuses on the utilization of proteins with catalytic properties. It offers recombinant RNases, exonucleases, alcohol-dehydrogenases, lipases, and proteases for applications in research and development; biocatalysts for the production of chemicals; and starch, cellulose, and hemicellulose hydrolyzing enzymes, as well as lipases and proteases to use as components in detergents and cleaning products for the food and feed industry. The company was founded by Marc Struhalla and Thomas Greiner-St?ffele in 2004 and is headquartered in Leipzig, Germany. | Health Technology |
- Borsa valori
- Insiders
- Marc Struhalla